Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Melanoma
Melanoma News & Features
Risks of Nonkeratinocyte Skin Cancers Higher in Solid Organ Transplant Recipients
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
Primary Care-Based Screening Ups Thin Melanoma Detection
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Does Aspirin Reduce the Risk of Invasive Melanoma in Older Adults?
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.
Melanoma Clinical Trials
Clinical Trial: Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
Clinical Trial: Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With Melanoma (Mel 51)
Clinical Trial: Study of Families With Melanoma
Clinical Trial: Individualized Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
Clinical Trial: Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Melanoma
Loading... 
Loading...